Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
452
First IPO Date
August 02, 2021
| Name | Title | Pay | Year Born |
| Jianhui Zhang | General Manager | 0 | 1958 |
| Qiang Huang | Financial Director & Accounting Supevisor | 0 | 1980 |
| Jin Zhou | Secretary to the Board | 0 | 1984 |
| Guo Xiong Tian | Deputy General Manager | 0 | 1979 |
| Jing Yu Zou | Deputy General Manager | 0 | 1976 |
| Jianguo Xia | Deputy GM & Director | 0 | 1974 |
| Bin Song | Deputy General Manager | 0 | 1962 |
Jiangsu gdk Biotechnology Co., Ltd. operates as a biotechnology firm specializing in the comprehensive research, development, manufacturing, and commercialization of human vaccines, alongside providing related services. Its current portfolio includes a quadrivalent split-virus influenza vaccine and a lyophilized human rabies vaccine. The company's pipeline is strategically focused on preventing major infectious diseases such as influenza, rabies, chickenpox, shingles, and pneumonia. This enterprise was established in 2008 and is headquartered in Taizhou, China.